HIGHLIGHTS
- who: Xue Zhou from the Emory University, United States have published the paper: Relapsed and refractory yolk sac tumor of the peritoneum (mesentery): A case report and literature review, in the Journal: (JOURNAL) of 28/06/2018
SUMMARY
Case report Yolk sac tumor (YST, endodermal sinus tumor) is the third common highly-malignant germ cell tumor, which often occurs in testes and ovaries. Currently, the overall cure rate for YST patients after surgery and chemotherapy is 80%. Currently, the standard first-line chemotherapy for extraglandular YST is BEP (bleomycin, etoposide, and cisplatin), in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.